Concerns Over Rising Medicine Prices In Mexico

12 December 1994

Despite public complaints to local health authorities and consumer protection groups, prices of medicines in Mexico have shown a steady upward spiral, ranging around 50% and in some cases even higher over the past half year. Neither the Federal Consumer Office nor the Ministry of Commerce, as well as private consumer organizations have been able to arrest the cost of drugs, including prescription medicines and patent products, reports the Marketletter's local correspondent.

Affected by the increases are said to be the poor, including salaried workers faced with minimum pay increases for unskilled members of the country's labor pool. Their last pay rise was a meagre 4% as the government exploits labor in its preoccupation with maintaining low inflation figures, despite rising prices for everything from food to medical attention by private doctors and hospitals.

Consumer organizations are preparing protests to be submitted to the new federal government now headed by newly-elected President Ernesto Zedillo Ponce de Leon, who took office December 1. The argument being presented is that necessary measures must be instituted to protect the population from excessive increases.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight